Skip to main content

Antares Pharma, Inc.

ATRSDelisted May 24, 2022
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001016169

Antares Pharma, Inc. was delisted on May 24, 2022; its insiders filed their last Form 4 on May 26, 2022; 177 institutions reported holding it in 13F filings for Q1 2022, worth $374.8M in total; no superinvestor held it.

Key figures

Insider buys
0
Open market, last 90 days
Insider sells
0
Open market, last 90 days
13F holders
177
Q1 2022, +16 vs. previous quarter
13F value
$374.8M
Reported value at the end of Q1 2022
Superinvestors holding
0
At the end of Q1 2022

Superinvestors holding ATRS, Q1 2022

Go to the superinvestors tab

No superinvestor reported holding ATRS at the end of Q1 2022.

Latest insider trades

Open-market purchases and sales by Antares Pharma, Inc. insiders from Form 4, newest first.

See all insider trades
Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jul 9, 2021 (view filing)Jul 81 dayGueth AntonDirectorSSale−100.0K$4.29−$429.0K−17.6%467.6K after

Top 10 13F holders, Q1 2022

The largest institutional positions in Antares Pharma, Inc. at the end of Q1 2022; share changes are against Q4 2021.

See all 177 holders
Institutions holding ATRS in Q1 2022
InstitutionSharesValue% of portfolioChange in sharesAction
BlackRock Inc.11,954,171$49.0M0.00%−69,025−0.6%Reduced
Rubric Capital Management LP10,900,000$44.7M2.08%+100,000+0.9%Added
Vanguard Group Inc8,643,155$35.4M0.00%+194,168+2.3%Added
Sargent Investment Group, LLC3,663,275$15.0M3.79%−32,200−0.9%Reduced
State Street Corp3,449,457$14.1M0.00%+108,267+3.2%Added
Amundi3,451,789$13.9M0.01%+953,452+38.2%Added
Stonepine Capital Management, LLC3,130,192$12.8M5.32%+832,832+36.3%Added
Russell Investments Group, Ltd.3,045,999$12.5M0.02%+1,903,508+166.6%Added
Geode Capital Management, LLC2,999,779$12.3M0.00%+63,817+2.2%Added
First Wilshire Securities Management Inc2,799,953$11.5M4.03%+33,512+1.2%Added